Mary T Szela Insider Trading $ABT ABBOTT LABORATORIES
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mary T Szela.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mary T Szela. Mary T Szela is Senior Vice President in ABBOTT LABORATORIES ($ABT) and Chief Executive Officer in QLT INC/BC ($QLTI) and Director in ALIMERA SCIENCES INC ($ALIM) and Chief Executive Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Kura Oncology, Inc. ($KURA) and Director in Receptos, Inc. ($RCPT) and Director in Coherus BioSciences, Inc. ($CHRS) and Director in Prometheus Biosciences, Inc. ($RXDX).
Mary T Szela in ABBOTT LABORATORIES
Trading Symbol: ABTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary T Szela: Senior Vice President
Holdings: 119,342 shares
Current Value: $5,118,578
Latest Transaction: Dec 16 2011
$ABT Market Capitalization: $62.37B
$ABT Previous Close: $42.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mary T Szela in ABBOTT LABORATORIES
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABT, AEGR, ALIM, CHRS, KURA, NVLN, RXDX, RCPT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | M | 53.63 | 53,201 | 2,852,904 | 0 | |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.46 | 500 | 27,230 | 119,342 | 119.8 K to 119.3 K (-0.42 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.45 | 2,781 | 151,412 | 119,842 | 122.6 K to 119.8 K (-2.27 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.44 | 3,200 | 174,208 | 122,623 | 125.8 K to 122.6 K (-2.54 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.43 | 2,700 | 146,961 | 125,823 | 128.5 K to 125.8 K (-2.10 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.43 | 212 | 11,538 | 128,523 | 128.7 K to 128.5 K (-0.16 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.42 | 2,488 | 135,397 | 128,735 | 131.2 K to 128.7 K (-1.90 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.41 | 5,275 | 287,013 | 131,223 | 136.5 K to 131.2 K (-3.86 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.41 | 2,300 | 125,132 | 136,498 | 138.8 K to 136.5 K (-1.66 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.40 | 4,500 | 244,800 | 138,798 | 143.3 K to 138.8 K (-3.14 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.40 | 3,700 | 201,262 | 143,298 | 147 K to 143.3 K (-2.52 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.39 | 1,900 | 103,341 | 146,998 | 148.9 K to 147 K (-1.28 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.39 | 100 | 5,439 | 148,898 | 149 K to 148.9 K (-0.07 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.39 | 1,600 | 87,016 | 148,998 | 150.6 K to 149 K (-1.06 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.38 | 5,195 | 282,504 | 150,598 | 155.8 K to 150.6 K (-3.33 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.38 | 5,500 | 299,063 | 155,793 | 161.3 K to 155.8 K (-3.41 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.37 | 900 | 48,933 | 161,293 | 162.2 K to 161.3 K (-0.55 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.37 | 100 | 5,437 | 162,193 | 162.3 K to 162.2 K (-0.06 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.36 | 2,100 | 114,156 | 162,293 | 164.4 K to 162.3 K (-1.28 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.36 | 2,100 | 114,146 | 164,393 | 166.5 K to 164.4 K (-1.26 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.35 | 1,550 | 84,243 | 166,493 | 168 K to 166.5 K (-0.92 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.35 | 900 | 48,911 | 168,043 | 168.9 K to 168 K (-0.53 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.34 | 100 | 5,434 | 168,943 | 169 K to 168.9 K (-0.06 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.34 | 200 | 10,867 | 169,043 | 169.2 K to 169 K (-0.12 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.33 | 2,500 | 135,825 | 169,243 | 171.7 K to 169.2 K (-1.46 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.33 | 300 | 16,298 | 171,743 | 172 K to 171.7 K (-0.17 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.33 | 500 | 27,163 | 172,043 | 172.5 K to 172 K (-0.29 %) |
Dec 16 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Buy | M | 53.63 | 53,201 | 2,852,904 | 172,543 | 119.3 K to 172.5 K (+44.58 %) |
Apr 01 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | M | 48.12 | 15,960 | 768,035 | 0 | |
Apr 01 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 49.26 | 2,425 | 119,456 | 119,342 | 121.8 K to 119.3 K (-1.99 %) |
Apr 01 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 49.25 | 13,535 | 666,599 | 121,767 | 135.3 K to 121.8 K (-10.00 %) |
Apr 01 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Buy | M | 48.12 | 15,960 | 768,035 | 135,302 | 119.3 K to 135.3 K (+13.37 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 48.13 | 100 | 4,813 | 119,342 | 119.4 K to 119.3 K (-0.08 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 48.12 | 2,800 | 134,736 | 119,442 | 122.2 K to 119.4 K (-2.29 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 48.11 | 100 | 4,811 | 122,242 | 122.3 K to 122.2 K (-0.08 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 48.11 | 11,067 | 532,433 | 122,342 | 133.4 K to 122.3 K (-8.30 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 48.14 | 2,500 | 120,350 | 133,409 | 135.9 K to 133.4 K (-1.84 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 48.17 | 700 | 33,719 | 135,909 | 136.6 K to 135.9 K (-0.51 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 48.30 | 1,988 | 96,026 | 136,609 | 138.6 K to 136.6 K (-1.43 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 47.64 | 9,845 | 469,016 | 138,597 | 148.4 K to 138.6 K (-6.63 %) |
Feb 23 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | A | 46.60 | 31,200 | 1,453,920 | 31,200 | |
Feb 23 2011 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Grant | A | 0.00 | 22,200 | 0 | 148,442 | 126.2 K to 148.4 K (+17.59 %) |
Dec 15 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Gift | G | 0.00 | 200 | 0 | 126,242 | 126.4 K to 126.2 K (-0.16 %) |
Aug 31 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 49.50 | 1,815 | 89,843 | 126,442 | 128.3 K to 126.4 K (-1.42 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.53 | 100 | 5,453 | 128,257 | 128.4 K to 128.3 K (-0.08 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.52 | 4,500 | 245,340 | 128,357 | 132.9 K to 128.4 K (-3.39 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.51 | 2,900 | 158,079 | 132,857 | 135.8 K to 132.9 K (-2.14 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.49 | 100 | 5,449 | 135,757 | 135.9 K to 135.8 K (-0.07 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.48 | 100 | 5,448 | 135,857 | 136 K to 135.9 K (-0.07 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.47 | 1,100 | 59,917 | 135,957 | 137.1 K to 136 K (-0.80 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.43 | 1,226 | 66,731 | 137,057 | 138.3 K to 137.1 K (-0.89 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.42 | 3,500 | 190,470 | 138,283 | 141.8 K to 138.3 K (-2.47 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.41 | 1,400 | 76,174 | 141,783 | 143.2 K to 141.8 K (-0.98 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.40 | 2,100 | 114,240 | 143,183 | 145.3 K to 143.2 K (-1.45 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.39 | 2,900 | 157,731 | 145,283 | 148.2 K to 145.3 K (-1.96 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.38 | 1,000 | 54,380 | 148,183 | 149.2 K to 148.2 K (-0.67 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.35 | 2,158 | 117,287 | 149,183 | 151.3 K to 149.2 K (-1.43 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 54.12 | 9,154 | 495,414 | 151,341 | 160.5 K to 151.3 K (-5.70 %) |
Feb 23 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | A | 54.50 | 28,700 | 1,564,150 | 28,700 | |
Feb 23 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Grant | A | 0.00 | 21,000 | 0 | 160,495 | 139.5 K to 160.5 K (+15.05 %) |
Feb 23 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Grant | A | 0.00 | 19,600 | 0 | 139,495 | 119.9 K to 139.5 K (+16.35 %) |
Feb 18 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 53.93 | 900 | 48,538 | 119,895 | 120.8 K to 119.9 K (-0.75 %) |
Feb 18 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 53.93 | 600 | 32,359 | 120,795 | 121.4 K to 120.8 K (-0.49 %) |
Feb 18 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 53.93 | 4,462 | 240,636 | 121,395 | 125.9 K to 121.4 K (-3.55 %) |
Feb 12 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | M | 53.00 | 390 | 20,670 | 0 | |
Feb 12 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | M | 50.70 | 57 | 2,890 | 0 | |
Feb 12 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 53.23 | 100 | 5,323 | 125,857 | 126 K to 125.9 K (-0.08 %) |
Feb 12 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 53.21 | 347 | 18,464 | 125,957 | 126.3 K to 126 K (-0.27 %) |
Feb 12 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Buy | M | 53.00 | 390 | 20,670 | 126,304 | 125.9 K to 126.3 K (+0.31 %) |
Feb 12 2010 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Buy | M | 50.70 | 57 | 2,890 | 125,914 | 125.9 K to 125.9 K (+0.05 %) |
Aug 28 2009 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 46.07 | 1,026 | 47,268 | 125,857 | 126.9 K to 125.9 K (-0.81 %) |
May 05 2009 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 41.57 | 8,122 | 337,593 | 0 | 8.1 K to 0 (-100.00 %) |
Mar 03 2009 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 50.58 | 4,072 | 205,962 | 126,883 | 131 K to 126.9 K (-3.11 %) |
Feb 24 2009 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | A | 54.14 | 50,400 | 2,728,656 | 50,400 | |
Feb 24 2009 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Grant | A | 0.00 | 35,500 | 0 | 130,955 | 95.5 K to 131 K (+37.19 %) |
Feb 19 2009 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 54.40 | 417 | 22,686 | 95,455 | 95.9 K to 95.5 K (-0.43 %) |
Feb 19 2009 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 54.94 | 1,228 | 67,466 | 95,872 | 97.1 K to 95.9 K (-1.26 %) |
Feb 06 2009 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | A | 56.98 | 2,996 | 170,712 | 2,996 | |
Feb 06 2009 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | M | 45.45 | 3,445 | 156,571 | 0 | |
Feb 06 2009 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 56.98 | 2,996 | 170,712 | 97,100 | 100.1 K to 97.1 K (-2.99 %) |
Feb 06 2009 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Buy | M | 45.45 | 3,445 | 156,571 | 100,096 | 96.7 K to 100.1 K (+3.56 %) |
Feb 05 2009 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | M | 54.40 | 2,090 | 113,696 | 0 | |
Feb 05 2009 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 56.00 | 2,090 | 117,040 | 96,651 | 98.7 K to 96.7 K (-2.12 %) |
Feb 05 2009 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Buy | M | 54.40 | 2,090 | 113,696 | 98,741 | 96.7 K to 98.7 K (+2.16 %) |
Sep 10 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | A | 57.01 | 2,036 | 116,072 | 2,036 | |
Sep 10 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | M | 45.45 | 2,474 | 112,440 | 3,445 | |
Sep 10 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 57.01 | 2,036 | 116,072 | 96,651 | 98.7 K to 96.7 K (-2.06 %) |
Sep 10 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Buy | M | 45.45 | 2,474 | 112,440 | 98,687 | 96.2 K to 98.7 K (+2.57 %) |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | A | 57.76 | 423 | 24,432 | 423 | |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | A | 57.76 | 1,743 | 100,676 | 1,743 | |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | A | 57.76 | 1,404 | 81,095 | 1,404 | |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | M | 45.45 | 538 | 24,451 | 5,919 | |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | M | 41.03 | 2,454 | 100,692 | 0 | |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | M | 32.61 | 2,488 | 81,136 | 0 | |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 57.57 | 1,026 | 59,067 | 96,213 | 97.2 K to 96.2 K (-1.06 %) |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 57.76 | 3,570 | 206,203 | 97,239 | 100.8 K to 97.2 K (-3.54 %) |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Buy | M | 45.45 | 538 | 24,451 | 100,809 | 100.3 K to 100.8 K (+0.54 %) |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Buy | M | 41.03 | 2,454 | 100,692 | 100,271 | 97.8 K to 100.3 K (+2.51 %) |
Aug 28 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Buy | M | 32.61 | 2,488 | 81,136 | 97,817 | 95.3 K to 97.8 K (+2.61 %) |
Jul 11 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | A | 57.37 | 10,819 | 620,686 | 10,819 | |
Jul 11 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | M | 45.45 | 12,376 | 562,474 | 6,457 | |
Jul 11 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 57.37 | 10,819 | 620,686 | 95,329 | 106.1 K to 95.3 K (-10.19 %) |
Jul 11 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Buy | M | 45.45 | 12,376 | 562,474 | 106,148 | 93.8 K to 106.1 K (+13.20 %) |
Jun 30 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 52.91 | 600 | 31,746 | 93,772 | 94.4 K to 93.8 K (-0.64 %) |
Jun 30 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 52.90 | 1,569 | 83,000 | 94,372 | 95.9 K to 94.4 K (-1.64 %) |
Jun 30 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 52.92 | 400 | 21,168 | 95,941 | 96.3 K to 95.9 K (-0.42 %) |
May 16 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | A | 54.40 | 1,011 | 54,998 | 1,011 | |
May 16 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | A | 54.40 | 2,090 | 113,696 | 2,090 | |
May 16 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | M | 43.00 | 1,158 | 49,794 | 0 | |
May 16 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | M | 42.50 | 2,676 | 113,724 | 0 | |
May 16 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 54.40 | 3,101 | 168,694 | 96,341 | 99.4 K to 96.3 K (-3.12 %) |
May 16 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Buy | M | 43.00 | 1,158 | 49,794 | 99,442 | 98.3 K to 99.4 K (+1.18 %) |
May 16 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Buy | M | 42.50 | 2,676 | 113,724 | 98,284 | 95.6 K to 98.3 K (+2.80 %) |
May 08 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | A | 53.00 | 390 | 20,670 | 390 | |
May 08 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | A | 53.00 | 16,220 | 859,660 | 16,220 | |
May 08 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | M | 41.97 | 447 | 18,761 | 0 | |
May 08 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | M | 41.03 | 18,789 | 770,945 | 2,454 | |
May 08 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 53.00 | 16,610 | 880,330 | 95,608 | 112.2 K to 95.6 K (-14.80 %) |
May 08 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Buy | M | 41.97 | 447 | 18,761 | 112,218 | 111.8 K to 112.2 K (+0.40 %) |
May 08 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Buy | M | 41.03 | 18,789 | 770,945 | 111,771 | 93 K to 111.8 K (+20.21 %) |
Mar 04 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 53.99 | 334 | 18,031 | 92,982 | 93.3 K to 93 K (-0.36 %) |
Mar 04 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 54.22 | 1,029 | 55,792 | 93,316 | 94.3 K to 93.3 K (-1.09 %) |
Feb 20 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | A | 55.56 | 97,700 | 5,428,212 | 97,700 | |
Feb 20 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 56.06 | 41 | 2,298 | 94,345 | 94.4 K to 94.3 K (-0.04 %) |
Feb 20 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 56.07 | 550 | 30,839 | 94,386 | 94.9 K to 94.4 K (-0.58 %) |
Feb 20 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 55.55 | 511 | 28,386 | 94,936 | 95.4 K to 94.9 K (-0.54 %) |
Feb 20 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Payment of Exercise | F | 55.55 | 1,227 | 68,160 | 95,447 | 96.7 K to 95.4 K (-1.27 %) |
Feb 20 2008 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Grant | A | 55.56 | 24,100 | 1,338,996 | 96,674 | 72.6 K to 96.7 K (+33.21 %) |
Sep 13 2007 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Sell | S | 52.50 | 8,327 | 437,168 | 72,574 | 80.9 K to 72.6 K (-10.29 %) |
Aug 29 2007 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Option Exercise | A | 52.14 | 35,500 | 1,850,970 | 35,500 | |
Aug 29 2007 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Grant | A | 52.14 | 2,000 | 104,280 | 80,901 | 78.9 K to 80.9 K (+2.53 %) |
Aug 29 2007 | ABT | ABBOTT LABORATORIE ... | Szela Mary T | Senior Vice Preside ... | Grant | A | 52.14 | 7,800 | 406,692 | 78,901 | 71.1 K to 78.9 K (+10.97 %) |
Page: 1